S Pestka

2.0k total citations
32 papers, 1.7k citations indexed

About

S Pestka is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, S Pestka has authored 32 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 11 papers in Oncology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in S Pestka's work include interferon and immune responses (9 papers), Cytokine Signaling Pathways and Interactions (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). S Pestka is often cited by papers focused on interferon and immune responses (9 papers), Cytokine Signaling Pathways and Interactions (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). S Pestka collaborates with scholars based in United States, Switzerland and Norway. S Pestka's co-authors include Lara S. Izotova, Sergei V. Kotenko, Harold Dickensheets, Raymond P. Donnelly, Ernest C. Borden, Tattanahalli L. Nagabhushan, Lawrence M. Pfeffer, Charles A. Dinarello, Bryan Williams and Paul P. Trotta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and JNCI Journal of the National Cancer Institute.

In The Last Decade

S Pestka

32 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S Pestka United States	16	1.1k	703	387	228	158	32	1.7k
G J Freeman United States	21	1.9k 1.8×	485 0.7×	443 1.1×	197 0.9×	218 1.4×	25	2.6k
Pedro Aparício Spain	25	1.0k 0.9×	386 0.5×	380 1.0×	143 0.6×	73 0.5×	46	1.6k
H Mostowski United States	16	1.2k 1.1×	403 0.6×	443 1.1×	337 1.5×	142 0.9×	22	1.9k
Ravi Hingorani United States	18	1.1k 1.0×	268 0.4×	434 1.1×	128 0.6×	64 0.4×	21	1.5k
Serguei V. Kotenko United States	11	1.1k 1.0×	892 1.3×	325 0.8×	88 0.4×	87 0.6×	11	1.5k
Claude Gimmi United States	14	1.4k 1.3×	450 0.6×	407 1.1×	234 1.0×	181 1.1×	30	1.9k
Glória László Hungary	17	1.7k 1.6×	352 0.5×	422 1.1×	247 1.1×	193 1.2×	28	2.2k
Yonglian Sun United States	27	1.5k 1.4×	516 0.7×	346 0.9×	86 0.4×	280 1.8×	39	2.1k
R Jerzy United States	10	1.2k 1.1×	298 0.4×	555 1.4×	138 0.6×	170 1.1×	12	1.8k
Dass S. Vinay United States	24	1.7k 1.6×	797 1.1×	302 0.8×	96 0.4×	126 0.8×	44	2.3k

Countries citing papers authored by S Pestka

Since Specialization

Citations

This map shows the geographic impact of S Pestka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Pestka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Pestka more than expected).

Fields of papers citing papers by S Pestka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Pestka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Pestka. The network helps show where S Pestka may publish in the future.

Co-authorship network of co-authors of S Pestka

This figure shows the co-authorship network connecting the top 25 collaborators of S Pestka. A scholar is included among the top collaborators of S Pestka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Pestka. S Pestka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kotenko, Sergei V., et al.. (2001). Identification of the Functional Interleukin-22 (IL-22) Receptor Complex. Journal of Biological Chemistry. 276(4). 2725–2732. 338 indexed citations

Bernabei, Paola, Eliana M. Coccia, L Rigamonti, et al.. (2001). Interferon-gamma receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death.. PubMed. 70(6). 950–60. 109 indexed citations

Lunn, Charles A., Lara S. Izotova, Olga Mirochnitchenko, et al.. (2000). Signaling by Covalent Heterodimers of Interferon-γ. Journal of Biological Chemistry. 275(30). 22995–23004. 22 indexed citations

Pfeffer, Lawrence M., Charles A. Dinarello, Ronald B. Herberman, et al.. (1998). Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.. PubMed. 58(12). 2489–99. 400 indexed citations

Pestka, S & Anthony Meager. (1997). Interferon standardization and designations.. PubMed. 17 Suppl 1. S9–14. 7 indexed citations

Marquet, Magda, Nancy A. Horn, Jennifer Meek, & S Pestka. (1996). Process development for the manufacture of plasmid DNA vectors for use in gene therapy. 20(4). 28–46. 31 indexed citations

Muthukumaran, Geetha, et al.. (1996). GENOMIC ORGANIzATION AND PROMOTER ANALYSIS OF THE GENE ifngr2 ENCODING THE SECOND CHAIN OF THE MOUSE INTERFERON‐γ RECEPTOR. Scandinavian Journal of Immunology. 44(6). 599–606. 12 indexed citations

Sarkar, Saumendra N., et al.. (1995). IFN-GAMMA AND B7 AS COSTIMULATORS OF ANTITUMOR IMMUNE-RESPONSES. International Journal of Oncology. 7(3). 501–9. 5 indexed citations

Ozzello, Luciano, et al.. (1995). UP-REGULATION OF A TUMOR-ASSOCIATED ANTIGEN (TAG-72) BY INTERFERON-ALPHA AND INTERFERON-GAMMA IN PATIENTS WITH CUTANEOUS BREAST-CANCER RECURRENCES. International Journal of Oncology. 6(5). 985–91. 6 indexed citations

10.

Sperber, Steven J., et al.. (1993). Anti-rhinoviral activity of recombinant and hybrid species of interferon alpha. Antiviral Research. 22(2-3). 121–129. 21 indexed citations

11.

Emanuel, Stuart L. & S Pestka. (1993). Human interferon-alpha A, -alpha 2, and -alpha 2(Arg) genes in genomic DNA. Journal of Biological Chemistry. 268(17). 12565–12569. 21 indexed citations

12.

Schwartz, B, et al.. (1992). Engineered Disulfide Bond Greatly Increases Specific Activity of Recombinant Murine Interferon-β. Journal of Interferon Research. 12(2). 139–143. 13 indexed citations

13.

Sperber, S J, et al.. (1992). Anti-HIV-1 Activity of Recombinant and Hybrid Species of Interferon-α. Journal of Interferon Research. 12(5). 363–368. 31 indexed citations

14.

Guadagni, Fiorella, J Schlom, W W Johnston, et al.. (1989). Selective Interferon-Induced Enhancement of Tumor-Associated Antigens on a Spectrum of Freshly Isolated Human Adenocarcinoma Cells. JNCI Journal of the National Cancer Institute. 81(7). 502–512. 77 indexed citations

15.

Langer, Jerome A., et al.. (1989). Creation of phosphorylation sites in proteins: construction of a phosphorylatable human interferon alpha.. Proceedings of the National Academy of Sciences. 86(2). 558–562. 68 indexed citations

16.

Giacomini, Patrizio, Roberto Gambari, Paola Nisticò, et al.. (1986). Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons.. UCL Discovery (University College London). 6(5). 877–84. 14 indexed citations

17.

Rashidbaigi, Abbas, Jerome A. Langer, Vincent Jung, et al.. (1986). The gene for the human immune interferon receptor is located on chromosome 6.. Proceedings of the National Academy of Sciences. 83(2). 384–388. 104 indexed citations

18.

Pestka, S, et al.. (1984). The human interferons: from the past and into the future.. PubMed. 37. 261–81. 5 indexed citations

19.

Herberman, R B, et al.. (1983). Interferon and natural killer (NK) cells.. PubMed. 41. 590–5. 14 indexed citations

20.

Pestka, S. (1981). Interferons. Part B. Introduction.. PubMed. 79(Pt B). xxxi–xxxiv. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact